stock pickMUemail_stock_pick
Is MU the Next Nvidia or Intel? Find Out Now!
# Is MU the Next Nvidia or Intel? Find Out Now!
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# Is MU the Next Nvidia or Intel? Find Out Now!
Read more# What Analysts Are Predicting for BMY—Don't Miss Out! ## Introduction Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company known for blockbuster drugs in…
Read more# VTGN Investors Alert: Secure Counsel Before Deadline!
Read more# CHRS: Don’t Miss Coherus’ New Stock Offering Opportunity! ## Overview – A Strategic Shift and Recent Offering Coherus Oncology, Inc. (NASDAQ: **CHRS**) – formerly Coherus…
Read more# MREO Alert: Class Action Deadline Approaches April 6, 2026!
Read more# SEI: Savy King Returns—A Game-Changer for Solaris! ## Business Overview & Leadership Moves Solaris Energy Infrastructure, Inc. (NYSE: **SEI**), formerly Solaris Oilfield…
Read more# C: Aardvark Grants Boost Citigroup's Nasdaq Prospects! ## Introduction Citigroup Inc. (NYSE: C) is a global banking giant undergoing a significant transformation under CEO Jane…
Read more# PLTR’s AIP Growth Sparks Rare Double Upgrade! ## Introduction: AIP Supercharges Sentiment Palantir Technologies (NYSE: PLTR) – a data analytics and AI software firm – has…
Read more# WMT: Jim Cramer Calls Walmart a Great American Company!
Read more# MRK Gains FDA Approval for KEYTRUDA®—Big Opportunity! ## Keytruda’s New Approval and Business Overview Merck & Co.
Read more# IRON: FDA's Response Could Shift EPP Treatment Landscape! ## Company Overview and EPP Background Disc Medicine, Inc.
Read more# EBS: FDA Approves NARCAN® Multipacks—Act Now! ## Overview Emergent BioSolutions (NYSE: **EBS**) is a specialty biopharma company focused on public health threats and…
Read more# Citigroup (C): Next Move After Orchestra BioMed’s “Grant” – What’s Ahead? ## Company Overview and Context Citigroup Inc. (NYSE: C) is one of the world’s largest banks, with a…
Read more# NGEN: CFO Retirement Sparks New Strategic Opportunities! ## Company Overview and CFO Transition NervGen Pharma Corp.
Read more# VTGN Investors: Class Action Info for Major Losses!
Read more# EDSA’s 1Q 2026 Results: What You Need to Know Now! ## Company Overview & 1Q 2026 Highlights **Edesa Biotech (NASDAQ: EDSA)** is a clinical-stage biotech focused on…
Read more# CHRS: Don't Miss Coherus' Key Stock Offering Update! ## Recent Stock Offering & Strategic Overview Coherus BioSciences (now **Coherus Oncology**, NASDAQ: CHRS) recently executed…
Read more# NGEN: Major Shift as CFO Bill Adams Retires! **Overview:** NervGen Pharma Corp. (TSXV/NASDAQ: **NGEN**) is a Vancouver-based clinical-stage biotech developing neuroreparative…
Read more# PROF: Don't Miss Q4 Results on March 5th! ## Company Overview and Q4 Earnings Preview **Profound Medical Corp.
Read more# F5 (FFIV): Scrutiny Over Alleged Long-Term Hack! **F5, Inc. (NASDAQ: FFIV)** is a Seattle-based technology company known for its application delivery controllers and security…
Read more